Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
31
1
2
3
4
5
6
8
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
31
1
2
3
Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 37th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO [...]
Allergan to Present at the 37th Annual J.P. Morgan Healthcare Conference
2019-01-07    
3:30 pm
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, [...]
Johnson & Johnson to Participate in 37th Annual JP Morgan Health Care Conference
2019-01-07    
3:30 pm
Johnson & Johnson (NYSE: JNJ) will participate in the 37th Annual JP Morgan Health Care Conference on Monday, Jan. 7th, at the Westin St. Francis in San Francisco.  Joseph J. [...]
Halozyme Therapeutics To Present At The 37th Annual J.P. Morgan Healthcare Conference
2019-01-09    
10:30 am
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference in San [...]
International Conference on Chemistry, Chemical Engineering and Chemical Process
2019-01-30 - 2019-01-31    
All Day
It is a great pleasure and an honor to extend to you a warm invitation to attend the "International Conference on Chemistry, Chemical Engineering and [...]
Streamline HCP Workflow • Drive Patient Education • Navigate the Specialty Prescribing Landscape
2019-02-01    
12:00 am
The original and most comprehensive conference series dedicated entirely to strategies for effective utilization of e-Rx and EHR technologies is back for 2019. Whether new [...]
Funding

HealthQx Receives Growth Capital From Health Enterprise Partners

it healthcare market

HealthQx, an innovator of value-based payment analytics software and services for providers, health systems and insurers, announced today an investment from Health Enterprise Partners II, LP (HEP). HEP is a growth equity firm whose investors include 25 leading hospital systems and health plans.

HealthQx was founded in 2012 as a Software as a Service (SaaS) company. The HealthQx payment analytics platform enables providers, health systems and insurers to operationalize value-based reimbursement models. The HealthQx payment platform has uniquely integrated the Healthcare Incentives Improvement Institute’s (HCI3) PROMETHEUS® payment models and rules engine to enhance their analytics platform capabilities to define and price episodes of care. “Our platform enables our customers to intelligently create and enter into various at-risk payment methodologies,” said Bill Conlan COO and co-founder of HealthQx. “We’re reducing the risk of these arrangements by providing insight into provider network performance, quality and cost efficiency. This is the actionable intelligence required to make these models work for payers and providers.”

This investment will enable HealthQx to accelerate its go-to-market efforts as well as enhance the development of the software suite. “The healthcare industry is rapidly transitioning towards value-based care models,” said Mark McAdoo, CEO and co-founder of HealthQx. “Our mission is to empower organizations with tools that enable them to succeed in this new operating environment, and deliver the highest value to their patients, members, and employees alike.”

“HealthQx has built a highly scalable technology infrastructure that includes industry-leading analytics and access to longitudinal claims data,” said David Tamburri, HEP General Partner. “Under the leadership of Mark and Bill, we see enormous prospects for HealthQx to support organizations deploying a bundled payment methodology.” Mr. Tamburri will also join HealthQx’s Board of Managers.

About HealthQx

HealthQx (www.HealthQx.com) delivers SaaS, data-driven solutions to payers, providers and partners who are on the leading edge of the shift from fee-for-service to transparent, value-based healthcare. Its product offering enables organizations to implement bundled payment models.

About Health Enterprise Partners

Health Enterprise Partners (www.hepfund.com) invests primarily in privately held, middle market companies in the healthcare information technology and healthcare service sectors. HEP’s strategy is to leverage its unique and extensive hospital system and health plan network, 25 members of which are investors in HEP’s funds. HEP seeks to invest in companies that improve the quality of the patient experience, reduce the cost of healthcare, and improve operating margins for their customers, typically hospital systems and/or health plans.

Source